-
This Saturday, November 16, you have the chance to ask Tinnitus Quest anything.
The entire Executive Board, including Dr. Dirk de Ridder and Dr. Hamid Djalilian are taking part.
The event takes place 7 AM Pacific, 9 AM Central, 10 AM Eastern, 3 PM UK (GMT).
➡️ Read More & Register!
Frequency Therapeutics — Hearing Loss Regeneration
- Thread starter RB2014
- Start date
Nope, they will start Phase 2a this year and report the results in 2H2020 (at least that's what they anticipate). After this, if everything goes as planned, they will probably Fast Track it or will receive some other FDA drug status to speed up the process. Anyway, at the end of 2020 we should know what the drug is able to do.
Also, there's the possibility that Astellas would also start clinical trials in other countries, and that might bring the drug to the market faster, although there's no official announcement regarding this.
Jomo
Member
- Sep 9, 2016
- 403
- Tinnitus Since
- 9/4/16
- Cause of Tinnitus
- going for a rim shot on the snare drum.
I have been out of the loop on this for a while and was reading through past posts to see what's going on... so thrilled they are public company now... we may be able to make some money off of our misery now lol, with that being said...
Could someone correct me if I am wrong, but from what I have read the clinical trials have had decent success with improving word recognition, nothing else, but they are going to continue with a new trial this quarter?
Could someone correct me if I am wrong, but from what I have read the clinical trials have had decent success with improving word recognition, nothing else, but they are going to continue with a new trial this quarter?
That's what they have said. The amount they used for the phase I was tiny, it was supposed to be only for proving safety. What was awesome is that they saw it was already improving the recipient's hearing, even with just that small dose.
Interesting choice of words. I thought at first that it was a meaningless word they'd chosen for marketing effect (which may still be true), but Harris's Principles of Internal Medicine has this:
"Damage to the brain can lead to a central deafness. The peripheral ear and the auditory nerve may function well but the central connections are damaged by tumour, trauma or other disease and the patient is unable to hear. Primary diseases of the central nervous system can present with hearing impairment. Characteristically, a reduction in clarity of hearing and speech comprehension is much greater than the loss of the ability to hear pure tone. Auditory testing shows normal otoacoustic emissions (OAE) and an abnormal auditory brainstem response (ABR)."
Member
Bob Langer originally said that ideally "one or two injections" would do the trick. We're now talking about doubling or quadrupling that for phase IIa. I'm curious as well, but this is still a downgrade from what they thought of originally.
We have to be cautious about being too optimistic here. There's still almost no evidence that this drug restores hearing in the 0-8000 Hz frequencies. All we have is 4 out of 16 patients that got the drug that improved 10 dB at 8000 Hz. Promising, yes, but they have plenty of work ahead of them, possibly having to switch to a different delivery method.
Could someone explain in a few words, how to read the sock of this company, to see whether its potential is increasing or decreasing?
https://www.marketwatch.com/investing/stock/FREQ
Does rising price of the share, mean that people are interested in investing into this company?
Why can't I find anywhere, that Flamingo bought 500 shares? Obviously this is good for the company, but I can't see any figures about the invested money.
https://www.marketwatch.com/investing/stock/FREQ
Does rising price of the share, mean that people are interested in investing into this company?
Why can't I find anywhere, that Flamingo bought 500 shares? Obviously this is good for the company, but I can't see any figures about the invested money.
Am I misinformed? Because I believe this is a lie. The first round of IPO is only available to major institutions, Goldman, Morgan Stanley, etc.
Click this link below and you may see the stock of Frequency Therapeutics being traded in real time on the public stock market. Anyone may purchase shares if they wish.
I followed the example of @Flamingo1 and purchased 100 shares. Maybe I will get rich if FX-322 is a big success.
http://bigcharts.marketwatch.com/quickchart/quickchart.asp?symb=freq
Rising shares means people are interested.
With small cap biotechs, it can be manipulated a little more easily though, so be cautious about just reading the current stock price (i.e. the "big guns" in the market can artificially inflate or deflate value to write calls or puts or let them expire worthless).
A stock price over a longer period of time (months to years) is a better indicator of the value of a company imo as sort term to near long term a lot can be messed with.
You also have to look at volume and the health of the market as a whole. Swings on bigger volume mean a lot more.
Jomo
Member
- Sep 9, 2016
- 403
- Tinnitus Since
- 9/4/16
- Cause of Tinnitus
- going for a rim shot on the snare drum.
I bought 50 shares... Best advice is don't be a pig and buy big...
If the stock goes down you can buy more and your average cost is even less...
If it goes up that's great but your average cost will still be less than what it is currently trading at.
If the stock goes down you can buy more and your average cost is even less...
If it goes up that's great but your average cost will still be less than what it is currently trading at.
No one has made money on the stock yet unless they got it for free and sold. Started at $14 and went down to $11.8 the first day. It's at $13.49 as of today though so it did bounce back. I can't see the stock going up unless they post some really good news.
I wonder if people bought in the initial offering thinking it would skyrocket on day one trying to make a quick buck and when they saw it going down just sold right away.
Does anyone know if any of the investors were awarded stock that they might have sold right away?
I wonder if people bought in the initial offering thinking it would skyrocket on day one trying to make a quick buck and when they saw it going down just sold right away.
Does anyone know if any of the investors were awarded stock that they might have sold right away?
- May 16, 2017
- 3,754
- Tinnitus Since
- 04/2011
- Cause of Tinnitus
- Syringing + Somatic tinnitus from dental work
In the US, FREQ is available on the NASDAQ Global Select Market. The best thing to do would be to contact a brokerage house in your country and ask them how to get access to that market and/or FREQ shares.
- Jan 25, 2013
- 3,574
- Tinnitus Since
- 2008
- Cause of Tinnitus
- TMJ disorder, airplane barotrauma, noise exposure.
I hope FREQ stock does better than EARS and OTIC as they both sold off dramatically. I don't know if FREQ having a public stock offering is a good thing or bad thing? I just hope their IT injections work for tinnitus.
JohnK
Member
- Nov 10, 2015
- 311
- Tinnitus Since
- 10/26/2015 (habituated) 5/13/2019
- Cause of Tinnitus
- Doxycycline (2015) Otimize ear drops [neomycin] (2019)
The Audion drug for the Regain project is essentially the exact same technology. It has been reported that a trial participant for that drug did in fact have their tinnitus and hyperacusis reduced. Hearing aids make many people's tinnitus go down or away entirely. If this does in fact improved hearing, the evidence is overwhelming that it will help.
Perhaps, but if they can't get frequencies below that to regenerate they might as well just call themselves a ultra high frequency tinnitus niche company instead of a company that wants to treat hearing loss.
Same delivery method, different mechanism (transdifferentation versus mitosis). I can imagine a combination therapy in the future where you use FX-322 first and then use the Regain drug to transdifferentiate those brand new supporting cells you got from FX-322.
What's the source of the trial participant testimony?
That's not totally true. FX-322 first multiplies the supporting cells and then transdifferentiates them into hair cells. Audion's drug does the transdifferentiation without multiplying the supporting cell first.
They both cause the supporting cell to transform into a hair cell. FX-322 just does it with depleting the supporting cells. The main mechanism is the restoration of the hair cells.
Log in or register to get the full forum benefits!
Similar threads
